Carotid Stent, AAA Market Entry: Boston Scientific Moves On Earn-Outs
This article was originally published in The Gray Sheet
Executive Summary
Boston Scientific intends to acquire carotid stent manufacturer EndoTex by year-end, following an anticipated FDA approval of NexStent